Expression pattern, regulation, and clinical significance of TOX in breast cancer

M Arora, S Kumari, J Singh, A Chopra… - Cancer Immunology …, 2021 - Springer
M Arora, S Kumari, J Singh, A Chopra, SS Chauhan
Cancer Immunology, Immunotherapy, 2021Springer
Thymocyte selection-associated high mobility group box protein (TOX) is a transcription
factor implicated in the regulation of T cell exhaustion during chronic infection and cancer.
While TOX is being targeted for cancer immunotherapy, limited information is available
about its significance in breast cancer and other solid tumors. We performed a
comprehensive analysis of TOX gene expression, its epigenetic regulation, protein
localization, relation to tumor infiltrating immune cell composition, and prognostic …
Abstract
Thymocyte selection-associated high mobility group box protein (TOX) is a transcription factor implicated in the regulation of T cell exhaustion during chronic infection and cancer. While TOX is being targeted for cancer immunotherapy, limited information is available about its significance in breast cancer and other solid tumors. We performed a comprehensive analysis of TOX gene expression, its epigenetic regulation, protein localization, relation to tumor infiltrating immune cell composition, and prognostic significance in breast cancer using publicly available datasets. Our results suggest an inverse correlation between TOX expression and DNA methylation in tumor cells. However, its expression is elevated in tumor infiltrating immune cells (TIICs), which may compensates for the total TOX levels in the tumor as a whole. Furthermore, higher TOX levels in tumors are associated with T cell exhaustion signatures along with presence of active inflammatory response, including elevated levels of T cell effector cytokines. Survival analysis also confirmed that higher expression of TOX is associated with better prognosis in breast cancer. Therefore, expression of TOX may serve as a novel prognostic marker for this malignancy.
Springer